An observational study in Peripheral Arterial Disease, sponsored by Gazi University. Completed at 2 sites in Turkey. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-24.
Sponsored by Gazi University · Observational
Among 22 studies in Peripheral Arterial Disease with a site in Turkey — 8 open to participants now, 10 under way, 2 of them phase 3. Peripheral Arterial Disease · Turkey.
Among the 22 studies in Peripheral Arterial Disease with a site in Turkey, this one is one of 2 that started in 2018, is one of 7 observational ones, and was the 3rd registered.
1,377 studies on the registry are indexed under Peripheral Arterial Disease; 275 are open to participants now.
Browse Peripheral Arterial Disease studies →8 of the 22 studies in Peripheral Arterial Disease with a site in Turkey are open now. Recruiting first, the newest first:
Mersin Medicalpark Hastanesi · Sites in Turkey
Izmir Democracy University · Sites in Turkey
Gazi University · Sites in Turkey
CSL Behring · Sites in Turkey, United States, Argentina and 32 more countries
Saglik Bilimleri Universitesi · Sites in Turkey
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 192 Peripheral Arterial Disease studies recruiting now, 138 (72%) set no upper age limit and 9 (5%) stop at 75 or younger; 13 take children under 18; 19 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 5
First in 2007; this study’s year is marked. 2 started in 2018.
This study's enrollment of 35 is below the median of 188 across 398 observational studies indexed under Peripheral Arterial Disease.
Median enrollment 51 across the 15 interventional studies, 52 across the 7 observational. Of the 12 that completed or were terminated, 2 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 22 have an industry lead sponsor. The 10 most frequent:
Gazi University is the lead sponsor of 551 studies on the registry; 102 are open to participants now.
Gazi University has 2 studies filed under Peripheral Arterial Disease — fewer than ten, so there is no comparison to draw.
1 of the studies in Peripheral Arterial Disease with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07550959Biruni UniversityEvaluation of the Effectiveness of Hybrid Cardiac Rehabilitation in Peripheral Artery Disease | 2027-01-16 |
Among the 22 studies in Peripheral Arterial Disease with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The primary aim of the study is to evaluate the maximal and submaximal exercise capacity in patients with peripheral artery disease (PAD). The secondary aim of the study is assessment of physical activity level, respiratory function, peripheral and respiratory muscle strength, respiratory muscle endurance, depression, quality of life, intermittent claudication and cardiovascular risk factors in patients with PAD.
Peripheral artery disease is characterized by reduced exercise capacity, physical activity level and intermittent claudication. The number of studies investigating maximal and submaximal exercise capacity and physical activity level in PAD is limited. There is also no study investigated pulmonary functions, respiratory muscle strength and endurance in this patient population. According to the sample size analysis 15 patients and 15 healthy individuals with similar demographic characteristics will be included the study. Patients and healthy individuals will be selected according to predetermined inclusion and exclusion criteria. The assessments will be completed in two days.Maximal exercise capacity will be assessed using cardiopulmonary exercise testing (CPET), functional exercise capacity using six minute stepper test, physical activity using multi-sensor activity monitor, pulmonary function using spirometry, respiratory muscle strength using mouth pressure device, peripheral muscle strength using hand held dynamometer, respiratory muscle endurance using incremental threshold loading test, depression using Beck depression inventory (Turkish version), life quality using SF-36 Health Survey (Turkish version), intermittent claudication using Walking Impairment Questionnaire (Turkish version)
At least 15 patients with PAD will be included in patients group and 15 healthy individuals will be included in control group
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients;
Exclusion Criteria:
Patients with;
Healthy controls: Ages 18-80 years will be included
Maximal exercise capacity will be assessed using cardiopulmonary exercise testing (CPET), functional exercise capacity using six minute stepper test, physical activity using multi-sensor activity monitor, pulmonary function using spirometry, respiratory muscle strength using mouth pressure device, peripheral muscle strength using hand held dynamometer, respiratory muscle endurance using incremental threshold loading test, depression using Beck depression inventory (Turkish version), life quality using SF-36 Health Survey (Turkish version), intermittent claudication using Walking Impairment Questionnaire (Turkish version)
Maximal exercise capacity will be assessed using cardiopulmonary exercise testing (CPET), functional exercise capacity using six minute stepper test, physical activity using multi-sensor activity monitor, pulmonary function using spirometry, respiratory muscle strength using mouth pressure device, peripheral muscle strength using hand held dynamometer, respiratory muscle endurance using incremental threshold loading test, depression using Beck depression inventory (Turkish version), life quality using SF-36 Health Survey (Turkish version), intermittent claudication using Walking Impairment Questionnaire (Turkish version)
Maximal exercise capacity
Cardiopulmonary exercise testing (Oxygen consumption measurement during test)
Time frame: First day
Functional exercise capacity
Six minute stepper test
Time frame: Second day
Physical activity
Multi sensor activity monitor
Time frame: Second day
Pulmonary function
Spirometry
Time frame: First day
Respiratory muscle strength
Mouth pressure device
Time frame: First day
Peripheral muscle strength
Hand held dynamometer
Time frame: Second day
Respiratory muscle endurance
Incremental threshold loading test
Time frame: Second day
Depression
Beck depression inventory (Turkish version)
Time frame: Second day
Life quality
SF-36 Health Survey (Turkish version)
Time frame: Second day
Intermittent claudication
Walking Impairment Questionnaire (Turkish version)
Time frame: Second day
Plan to share: No
Ran from Jan 2018 to primary completion in Dec 2018, 11 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.